Yes, in effect, the $131 million also supported, at the provincial level, the ability to fund that type of validation study and research. In addition, from the health perspective, some of the honourable members would recognize that one of the other institutions that was established in Canada was a research group called PrioNet, in addition to the Alberta-based Prion Research Institute. Both of those receive federal funding, and this is one of the areas they are pursuing, both with research in Canada and internationally on disposal and deactivation of prions, including SRM material, through various processes.
The committee will recall from one of our previous appearances that there is a company in Canada with technology for alkaline hydrolysis, as well, which is continuing to be validated and which is extremely promising for commercial application.